Previous 10 | Next 10 |
PITTSBURGH, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs, anno...
2023-11-06 11:43:02 ET Krystal Biotech Inc. (KRYS) Q3 2023 Earnings Conference Call November 06, 2023 08:30 A.M. ET Company Participants Meg Dodge - VP, Investor Relations & Corporate Communications Krish Krishnan - Chairman & Chief Executive Officer Suma...
2023-11-06 07:07:09 ET More on Krystal Biotech Krystal Biotech: FDA Approval Of Vyjuvek And Further Pipeline Enhancement Cantor starts Krystal Biotech at overweight, cites Vyjuvek launch Seeking Alpha’s Quant Rating on Krystal Biotech Historical earnin...
CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...
Krystal Biotech Inc. (KRYS) is expected to report $-1.1 for Q3 2023
2023-11-05 11:08:50 ET Major earnings expected before the bell on Monday include: Axsome Therapeutics ( AXSM ) Brookfield Asset Management ( BAM ) BioNTech ( BNTX ) Ceragon Networks ( CRNT ) DISH Network ( DISH ) For further details see: N...
2023-11-03 11:34:51 ET More on Krystal Biotech Krystal Biotech: FDA Approval Of Vyjuvek And Further Pipeline Enhancement Cantor starts Krystal Biotech at overweight, cites Vyjuvek launch Krystal Biotech wins FDA nod to run trial for gene therapy Seeking Alpha...
PITTSBURGH, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs, will...
2023-10-25 19:00:31 ET More on Krystal Biotech Krystal Biotech: FDA Approval Of Vyjuvek And Further Pipeline Enhancement Krystal Biotech: Pioneering Rare Disease Gene Therapies Krystal Biotech wins FDA nod to run trial for gene therapy Berenberg starts Krysta...
PITTSBURGH, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs, ann...
News, Short Squeeze, Breakout and More Instantly...
PITTSBURGH, July 26, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its second quarter 2024 financial results on Monday, August 5, 2024, prior to the open of U....
A look at the top 10 most actives in the United States Serve Robotics Inc. (SERV) rose 187.1% to $7.55 on volume of 255,453,115 shares 60 Degrees Pharmaceuticals Inc. (SXTP) rose 10.2% to $0.271 on volume of 224,640,171 shares NVIDIA Corporation (NVDA) fell 2.6% to $117.93 on volume of 21...
A look at the top 10 most actives in the United States 60 Degrees Pharmaceuticals Inc. (SXTP) rose 98.3% to $0.4878 on volume of 116,444,604 shares NVIDIA Corporation (NVDA) fell 0.2% to $120.8 on volume of 26,900,560 shares Serve Robotics Inc. (SERV) rose 61.2% to $4.2399 on volume of 25...